The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MELODY (Methods for Localization of Different Types of Breast Lesions): A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET).
 
Maggie Banys-Paluchowski
Consulting or Advisory Role - Amgen; AstraZeneca; Canon Medical System; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis/Pfizer; Onkowissen; pfm medical; Pierre Fabre; Roche; Samsung; Seagen; Sirius Medical
Speakers' Bureau - Amgen; AstraZeneca; Canon Medical System; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis/Pfizer; Onkowissen; pfm medical; Pierre Fabre; Roche; Samsung; Seagen; Sirius Medical
Research Funding - Endomagnetics (Inst); Exact Sciences; Hologic; mammotome (Inst); Merit Medical Systems (Inst); Sirius Medical
Travel, Accommodations, Expenses - Lilly; Pfizer
 
Thorsten Kühn
Speakers' Bureau - AstraZeneca; Daiichi Sankyo Pharmaceutical; Exact Sciences; Gilead Sciences; MSD; Pfizer
Research Funding - Endomag; Hologic; Mammotome; Merit Medical Systems; Sirius Medical
 
Yazan Masannat
No Relationships to Disclose
 
Isabel T. Rubio
No Relationships to Disclose
 
Jana de Boniface
No Relationships to Disclose
 
Nina Ditsch
Consulting or Advisory Role - Gilead Sciences; Lilly O.; MSD; Novartis
Speakers' Bureau - Daiichi Sankyo Pharmaceutical; Gilead Sciences; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - Gilead Sciences; Pfizer
 
Andreas Karakatsanis
Honoraria - Pfizer
Consulting or Advisory Role - Resitu
Research Funding - Endomag
 
Rajiv V Dave
Speakers' Bureau - Endomag; Roche
Research Funding - Co-CI of the Ibranet Localisation portfolio, funded by industry partners
Travel, Accommodations, Expenses - Endomag
 
Shelley Potter
No Relationships to Disclose
 
Ashutosh Kothari
No Relationships to Disclose
 
Oreste Davide Gentilini
No Relationships to Disclose
 
Walter Paul Weber
No Relationships to Disclose
 
Natalia Krawczyk
No Relationships to Disclose
 
Steffi Hartmann
No Relationships to Disclose
 
Guldeniz Karadeniz Cakmak
No Relationships to Disclose
 
Markus Hahn
No Relationships to Disclose
 
Michael Patrick Lux
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Endomag; Genomic Health; Grunenthal; Hexal; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; Roche Pharma AG; SamanTree Medical
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Endomag; Genomic Health; Grunenthal; Hexal; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche Pharma AG
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai Germany; Endomag; Endomag; Exact Sciences; Grunenthal; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; Roche Pharma AG
Research Funding - Daiichi Sankyo/Astra Zeneca (Inst); German Breast Group (Inst); Grunenthal (Inst); MSD Oncology (Inst); PRAEGNANT Network (Inst); Roche (Inst); SamanTree Medical (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche Pharma AG
Other Relationship - Medac
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Endomag; Pfizer
 
Marjolein Smidt
No Relationships to Disclose
 
Neslihan Cabioglu
No Relationships to Disclose
 
James Harvey
Research Funding - Merit Medical Systems